-golide
Ergoline drugs that activate dopamine receptors.
- Drugs ending in -golide: 3
- Approved somewhere: 1
- With a US drug page: 1
- Stem
- -golide
- Class
- Ergoline drugs that activate dopamine receptors
- Most common targets
- DRD2 (2), Dopamine receptor (1), SSTR2 (1), SSTR5 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -golide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Pergolide | Approved | Dopamine receptor | Dopamine receptor agonist |
| Onzigolide | Phase 2 | SSTR2, DRD2, SSTR5 | Somatostatin receptor 2 agonist |
| Quinagolide | Phase 2 | DRD2 | Dopamine D2 receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO